EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities

Jiawen Xie, Hayam Hamdy, Eyad Elkord

Trends in Pharmacological Sciences · 2026-11 · 47 (11) · 1235-1251

DOI: 10.1016/j.tips.2026.03.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2026-11. Verfasst von Jiawen Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryNeoplasmsImmunotherapyImmune Checkpoint InhibitorsHumansAnimalsTumor MicroenvironmentSignal Transduction

Stichwörter der Autor:innen

FOXP3immune modulationregulatory T cellstumor microenvironment

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
  • Yunnan Key Laboratory of Cell Metabolism and Diseases, Center for Life Sciences, School of Life Sciences, Yunnan University, Kunming 650091, China.
  • Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China; Biomedical Res…

Zitieren

APA

Xie, J., Hamdy, H., & Elkord, E. (2026). Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. Trends in Pharmacological Sciences, 47(11), 1235-1251. https://doi.org/10.1016/j.tips.2026.03.007

Vancouver

Xie J, Hamdy H, Elkord E. Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. Trends in Pharmacological Sciences. 2026;47(11):1235-1251. doi:10.1016/j.tips.2026.03.007

BibTeX
@article{Xie2026,
  author = {Xie, Jiawen and Hamdy, Hayam and Elkord, Eyad},
  title = {Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities},
  journal = {Trends in Pharmacological Sciences},
  year = {2026},
  volume = {47},
  number = {11},
  pages = {1235--1251},
  doi = {10.1016/j.tips.2026.03.007}
}
Kostenlos starten →